Acetylcysteine Solution for Inhalation
Formulation (FDF) · for Inhalation · 10%/4ml; 20%/4ml; 10%/10ml; 20%/20ml
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Acetylcysteine Solution for Inhalation
- Dosage Form
- for Inhalation
- Strength
- 10%/4ml; 20%/4ml; 10%/10ml; 20%/20ml
- Therapy Area
- Respiratory
- Indication
- Mucolytic therapy; Paracetamol overdose
- Current Status
- Official FDF licensing catalog (UB269)
- GMP Certification
- CN - NMPA; EU - EMA; US - FDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price